Estrogens and atherosclerosis

Annual Review of Pharmacology and Toxicology

Volumn 37, Issue , 1997, Pages 477-515

  Nathan, Lauren ^a   Chaudhuri, Gautam ^a  

^a UNIVERSITY OF CALIFORNIA   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ESTRADIOL; ESTROGEN; ETHINYLESTRADIOL;

ATHEROSCLEROSIS; CARDIOVASCULAR DISEASE; ESTROGEN THERAPY; HUMAN; PRIORITY JOURNAL; REVIEW;

ANIMALS; ARTERIOSCLEROSIS; BIOLOGICAL TRANSPORT; CHOLESTEROL; ESTROGEN REPLACEMENT THERAPY; ESTROGENS; FEMALE; HUMANS; LIPOPROTEINS; MONOCYTES; NITRIC OXIDE;

ANIMALIA;

EID: 0031011749     PISSN: 00664251     EISSN: None     Source Type: Book Series    
DOI: None     Document Type: Review

References (280)

1. Ross R. 1995. Cell biology of atherosclerosis. Annu. Rev. Physiol. 57:791-804
2. Kannel WB, Hjortland MC, McNamara PM, Gordon T. 1976. Menopause and risk of cardiovascular disease. The Framingham Study. Ann. Intern. Med. 85:447-52
3. Bush TL. 1990. The epidemiology of cardiovascular disease in postmenopausal women. Ann. NY Acad. Sci. 592:263-71
4. Stampfer MJ, Colditz GA. 1991. Estrogen replacement therapy and coronary heart disease: a quantitative assessment of the epidemiologic evidence. Prev. Med. 20:47-63
5. Green A, Bain C. 1993. Epidemiological overview of oestrogen replacement and cardiovascular disease. Balliere's Clin. Endocrinol. Metab. 7:95-112
6. Master AM, Dack S, Jafee HL. 1939. Age, sex and hypertension in myocardial infarction due to coronary occlusion. Arch. Intern. Med. 64:767-86
7. Oliver MF, Boyd GS. 1955. Coronary atherogenesis - an endocrine problem? Minn. Med. 38:794-99
8. McGee D. 1973. The probability of developing certain cardiovascular diseases in eight years at specified values of some characteristics. In Framingham Study 18-Year Followup, Am. Epidemiological Investigation of Cardiovascular Disease, ed. WB Kannel, T Gordon, pp. 74-618. Washington DC: NIH
9. Gertler MM, White PO. 1954. Coronary Heart Disease in Young Adults. Cambridge, MA: Harvard Univ. Press
10. Hamm TE, Kaplan JR, Clarkson TB, Bullock BC. 1983. Effects of gender and social behavior on the development of coronary artery atherosclerosis in cynomolgus macaques. Atherosclerosis 48:221-33
11. Hayashi T, Fukuto JM, Ignarro LJ, Chaudhuri G. 1995. Gender differences in atherosclerosis: possible role of nitric oxide. J. Cardiovasc. Pharmacol. 26:792-802
12. McGill HC Jr, Stern MP. 1979. Sex and atherosclerosis. Atheroscler. Rev. 4:157-242
13. Bush TL, Barrett-Connor E. 1985. Non-contraceptive estrogen use and cardiovascular disease. Epidemiol. Rev. 7:80-104
14. Adams MR, Kaplan JR, Clarkson TB, Koritnik DR. 1985. Ovariectomy, social status and atherosclerosis in cynomolgus monkeys. Arteriosclerosis 5:192-200
15. Hunt K, Vessery M, McPherson K. 1990. Mortality in a cohort of long-term users of hormone replacement therapy: an updated analysis. Br. J. Obstet. Gynecol. 97:1080-86
16. Henderson BE, Paganini-Hill A, Ross RK. 1990. Decreased mortality in users of estrogen replacement therapy. Arch. Intern. Med. 151:75-78
17. Stampfer MJ, Colditz GA, Willett WC, Manson JE, Rosner B, et al. 1991. Postmenopausal estrogen therapy and cardiovascular disease. Ten-year followup from the Nurse's Health Study. N. Engl. J. Med. 325:756-62
18. Wolf PH, Madans JH, Finucane FF, Higgins M, Kleinman JC. 1991. Reduction of cardiovascular disease-related mortality among postmenopausal women who use hormones: evidence from a national cohort. Am. J. Obstet. Gynecol. 164:489-94
19. Ettinger B, Friedman GD, Bush T, Quesenberry CP Jr. 1996. Reduced mortality associated with long-term postmenopausal estrogen therapy. Obstet. Gynecol. 87:6-12
20. Adams MR, Kaplan JR, Manuck SB, Koritnik DR, Parks JS, et al. 1990. Inhibition of coronary artery atherosclerosis by 17-beta estradiol in ovariectomized monkeys. Lack of an effect of added progesterone. Arteriosclerosis 10:1051-57
21. Haarbo J, Leth-Espensen P, Stender S, Christiansen C. 1991. Estrogen monotherapy and combined estrogen-progestogen replacement therapy attenuate aortic accumulation of cholesterol in ovariectomized cholesterol-fed rabbits. J. Clin. Invest. 87:1274-79
22. Haarbo J, Fischer Hansen B, Christiansen C. 1991. Hormone replacement therapy prevents coronary artery disease in ovariectomized cholesterol-fed rabbits. Acta Pathol. Microbiol. Immunol. Scand. 99:721-27
23. Pick R, Stamler J, Rodband S. 1952. Inhibition of coronary atherosclerosis of estrogen in cholesterol-fed chickens. Circulation 6:276-81
24. Moskowitz MS, Moskowitz AA, Bradford W. 1956. Changes in serum lipids and coronary arteries of the rat in response to estrogen. Arch. Pathol. 61:245-63
25. Hanash KA, Kottke BA, Greene LF, Titus JL. 1972. Effects of conjugated estrogens on spontaneous atherosclerosis in pigeons. Arch. Pathol. 93:184-89
26. Ross R. 1993. The pathogenesis of atherosclerosis: a perspective for the 1990s. Nature 62:801-9
27. Berliner JA, Navab M, Fogelman AM, Frank JS, Demer LL, et al. Atherosclerosis: basic mechanisms. Oxidation, inflammation and genetics. Circulation 91:2488-96
28. Navab M, Berliner JA, Watson AD, Hama SY, Territo MC, et al. 1996. The Yin and Yang of oxidation in the development of the fatty streak. A review based on the 1994 George Lyman Duff Memorial lecture. Arterioscler. Thromb. Vasc. Biol. 16:831-42
29. Rosenfeld ME. 1996. Cellular mechanisms in the development of atherosclerosis. Diabetes Clin. Pract. 30:1-11
30. Fuster V, Badimon L, Badimon JJ, Chesebro JH. 1992. The pathogenesis of coronary artery disease and the acute coronary syndromes. N. Eng. J. Med. 326:242-50
31. Faggiotto A, Ross R, Harker L. 1984. Studies of hypercholesterolemia in the non human primates. 1. Changes that lead to fatty streak formation. Arteriosclerosis 4:323-40
32. Stary HC. 1989. Evolution and progression of atherosclerotic lesions in coronary arteries of children and young adults. Arteriosclerosis 9(Suppl. 1): 119-32
33. Cornhill JF, Barrett WA, Herderick EE, Mahley RW, Fry DL. 1985. Topographic study of sudanophilic lesions in cholesterol fed mini-pigs by image analysis. Arteriosclerosis 5:415-26
34. Wissler RW, Vesselinovitch D. 1983. Atherosclerosis-relationship to coronary blood flow. Am. J. Cardiol. 52(2):2A
35. Stary HC, Chandler AB, Glagov S, Guyton JR, Insull W, et al. 1994. A definition of initial, fatty streak and intermediate lesions of atherosclerosis. Circulation 89:2462-78
36. Stary HC, Chandler AB, Dinsmore RE, Ruster V, Glagov S, et al. 1995. A definition of advanced types of atherosclerotic lesions and a histological classification of atherosclerosis. Arterioscler. Thromb. Vasc. Biol. 15:1512-31
37. Qiao JH, Fishbein MC, Demer LL, Lusis AJ. 1995. Genetic determination of cartilaginous metaplasia in mouse aorta. Arlerioscler. Thromb. Vasc. Biol. 15:2265-72
38. Bostrom K, Watson KE, Horn S, Wortham C, Herman IM, Demer LL. 1993. Bone Morphogenetic protein expression in human atherosclerotic lesions. J. Clin. Invest. 91:1800-9
39. Kushwaha RS, Hazzard WR. 1981. Exogenous estrogens attenuate dietary hypercholesterolemia and atherosclerosis in the rabbit. Metabolism 30:359-66
40. Henriksson P, Stamberger M, Eriksson M, Rudling M, Diczfalusy U, et al. 1989. Oestrogen induced changes in lipoprotein metabolism: role in prevention of atherosclerosis in the cholesterolfed rabbit. Eur. J. Clin. Invest. 19:395-403
41. Knopp RH, Zhu X, Bonet B, Bagatell C. 1996. Effects of sex steroid hormones on lipoproteins, clotting and the arterial wall. Semin. Reprod. Endocrinol 14:15-27
42. Cheng LP, Kuwahara M, Jacobsson J, Foegh ML. 1991. Inhibition of myointimal hyperplasia and macrophage infiltration by estradiol in aorta allografts. Transplantation 52:967-72
43. Kovanen PT, Brown MS, Goldstein JL. 1979. Increased binding of low density lipoprotein to liver membranes from rats treated with 17 alpha ethinyl estradiol. J. Biol. Chem. 254:11367-73
44. Floren CH, Kushwaha RS, Hazzard WR, Albers J. 1981. Estrogen-induced increase in uptake of cholesterol-rich very low density lipoproteins in perfused rabbit liver. Metabolism 30:367-75
45. Chao Y, Windler EE, Chen GC, Havel RJ. 1979. Hepatic catabolism of rat and human lipoproteins in rats treated with 17 alpha-ethinyl estradiol. J. Biol. Chem. 254:11360-66
46. Ma PTS, Yamamoto P, Goldstein JL, Brown MS. 1986. Increased mRNA for low density lipoprotein receptor in livers of rabbits treated with 17 alpha ethinyl estradiol. Proc. Natl. Acad. Sci. USA 83:792-96
47. Demacker PNM, Staels B, Stalenhoef AFH, Anwerx J. 1991. Increased removal of β-very low density lipoproteins after ethinyl estradiol is associated with increased mRNA levels for hepatic lipase, lipoprotein lipase and low density lipoprotein receptor in Watanabe heritable hyperlipidemic rabbits. Arterioscler. Thromb. 11:1652-59
48. Srivastava RAK, Bauman D, Schonfeld G. 1993. In vivo regulation of low density lipoprotein receptors by estrogen differs at the post transcriptional level in rat and mouse. Eur. J. Biochem. 216:527-38
49. Wahl PW, Walden CE, Knopp RH, Wallace R, Rifkind B. 1983. Effect of estrogen/progestin potency on lipid/lipoprotein cholesterol. N. Engl J. Med. 308:862-67
50. Applebaum-Bowden D, McClean P, Steinmetz A, Fontana D, Matthys C. 1989. Lipoprotein, apolipoprotein and lipolytic enzyme changes following estrogen administration in postmenopausal women. J. Lipid Res. 30:1895-906
51. Walsh BW, Schiff I, Rosner B, Greenberg L, Ravnikar V, Sacks FM. 1991. Effects of postmenopausal estrogen replacement on the concentrations and metabolism of plasma lipoproteins. N. Engl. J. Med. 325:1196-204
52. Beisiegel U, Weber W, Bengtsson-Olivacrona G. 1991. Lipoprotein lipase enhances the binding of chylomicrons to low density receptor-related protein. Proc. Natl. Acad. Sci. USA 88:8342-46
53. Berr F, Eckel RH, Kern F Jr. 1986. Contraceptive steroids increase hepatic uptake of chylomicron remnants in young women. J. Lipid Res. 27:645-51
54. Knopp RH, Zhu X, Bonet B. 1994. Effects of estrogens on lipoprotein metabolism and cardiovascular disease in women. Atherosclerosis 110:583-91
55. Knopp RH, Zhu X-D, Lau J, Walden C. 1994. Sex hormones and lipid interactions: implications for cardiovascular disease in women. The Endocrinologist 4:286-301
56. Knopp RH. 1989. The effects of oral contraceptives and postmenopausal estrogens on lipoprotein physiology and atherosclerosis. In Oral Contraception, ed. HW Habbe, H Rekers, pp 31-45. Carnforth, UK: Parthenon
57. Sacks FM, Gerhard M, Walsh BW. 1995. Sex hormones, lipoproteins and vascular reactivity. Curr. Opin. Lipidol. 6:161-66
58. Subbiah MTR. 1977. Effect of estrogens on the activities of cholesteryl ester synthetase and cholesteryl ester hydrolases in pigeon aorta. Steroids 30:259-65
59. Hough JL, Zilversmit DB. 1986. Effect of 17 beta estradiol on aortic cholesterol content and metabolism in cholesterol fed rabbits. Arteriosclerosis 6:57-63
60. Adams MR, Clarkson TB, Koritnik DR, Nash HA. 1987. Contraceptive steroids and coronary artery atherosclerosis in cynomolgus macaques. Fertil. Steril. 47:1010-18
61. DurringtonPN.IsholaM, Hunt L, Arrol S, Bhatnagar D. 1988. Apoliproteins (a), A1 and B and parenteral history in men with early onset ischaemic heart disease. Lancet 1:1070-73
62. Hoefler G, Harnoncourt F, Paschke E, Mirtl W, Pfeiffer KH, Kostner GM. 1988. Lipoprotein Lp(a): a risk factor for myocardial infarction. Arteriosclerosis 8:398-401
63. Armstrong VW, Cremer P, Eberle E, Manke A, Schulze F, et al. 1986. The association between serum Lp(a) concentrations and angiographically assessed coronary atherosclerosis. Atherosclerosis 62:249-57
64. MBewu AD, Durrington PN. 1990. Lipoprotein(a): structure, properties and possible involvement in thrombogenesis and atherogenesis. Atherosclerosis 85:1-14
65. Hajjar KA, Gavish D, Breslow JL, Nachman RL. 1989. Lipoprotein (a) modulation of endothelial cell surface fibrinolysis and its potential role in atherosclerosis. Nature 339:303-5
66. Dahlen GH, Guyton JR, Attar M, Farmer JA, Kautz JA, Getts AM. 1986. Association of levels of lipoprotein Lp(a) plasma lipids and other lipoproteins with coronary artery disease documented by angiography. Circulation 74:758-65
67. Meilahn EN, Kuller LH, Matthews KA, Stein EA. 1991. Lp(a) concentrations among pre and postmenopausal women overtime: the healthy women study. Circulation 84(Suppl. 2):2170 (Abstr.)
68. Mosca L, Bowlin S, Davidson L, Jenkins P, Pearson TA. 1991. Estrogen replacement therapy and lipoprotein (a). Circulation 84(Suppl. 2):2169 (Abstr.)
69. Melchior GW, Castle CK, Vidmar TJ, Polites HG, Marrotti RR. 1990. Apo A-1 metabolism in cynomolgus monkeys: male-female differences. Biochem. Biophys. Acta 1043:97-105
70. Schaefer EJ, Foster DM, Zech LA, Lindgren FT, Brewer HB, Levy RI. 1983. The effects of oestrogen administration on plasma lipoprotein metabolism in premenopausal females. J. Clin. Endocrinol. Metab. 57:262-67
71. Newnham HH. 1993. Oestrogens and atherosclerotic vascular disease: lipid factors. Baillere's Clin. Endocrinol. Metab. 1:61-93
72. Tall AR. 1990. Plasma high density lipoproteins. Metabolism and relationship to atherogenesis. J. Clin. Invest. 86:379-84
73. Breckenridge WC, Little JA, Alaupovic P, Wang CS, Kuksis A, et al. 1982. Lipoprotein abnormalities associated with a familial deficiency of hepatic lipase. Atherosclerosis 45:161-79
74. Homma Y, Irie N, Yano Y, Nakamura H, Coto Y. 1982. Conversion of low-density lipoprotein 1 (LDL1, 1.019 < d1.045) to low density lipoprotein 2 (LDL2 1.045 < d < 1.063). Jpn. Circ. J. 46:645-50
75. Newnham HH, Barter PJ. 1990. Synergistic effects of lipid transfers and hepatic lipase in the formation of very small high density lipoproteins during incubation of human plasma. Biochim. Biophys. Acta 1044:57-64
76. Miller NE. 1987. Association of high density lipoprotein subclasses and apolipoproteins with ischaemic heart disease and coronary atherosclerosis. Am. Heart J. 113:589-97
77. Basdevant A, deLignieres B, Simon P, Blache D, Ponsin G, Guy-Grand B. 1991. Hepatic lipase activity during oral and parenteral 17β estradiol replacement therapy: high density lipoprotein increase may not be antiatherogenic. Fertil. Steril. 55:1112-17
78. Jansen H, VanTol A, Hulsmann WC. 1980 On the metabolic function of heparin-releasable liver lipase. Biochem. Biophys. Res. Commun. 92:53-59
79. Bamberger M, Click JM, Rothblat GH. 1983. Hepatic lipase stimulates the uptake of high density lipoprotein cholesterol by hepatoma cells. J. Lipid Res. 24:869-74
80. Pansini F, Bonaccorsi G, Genovesi F, Folegatti MR, Bagni B, et al. 1990. Influence of estrogens on serum tree fatty acid levels in women. J. Clin. Endocrinol. Metab. 71:1387-89
81. Barter PJ, Chang LBF, Rajaram OV. 1990. Sodium oleate dissociates the heteroexchange of cholesterylesters and triacylglycerol between HDL and triacyl-glycerol rich lipoproteins. Biochem. Biophys. Acta 1047:294-97
82. Steinberg D, Parthasarathy S, Carew TE, Khoo JC, Witztum JL. 1989. Beyond cholesterol: modifications of low density lipoprotein that increases its atherogenicity. N. Engl. J. Med. 320:915-24
83. Young SG, Parthasarathy S. 1994. Why are low density lipoproteins atherogenic? West. J. Med. 160:153-64
84. Frank JS, Fogelman AM. 1989. Ultrastructure of the intima in WHHL and cholesterol-fed rabbit aortas prepared by ultra-rapid freezing and freeze-etching. J. Lipid Res. 30:967-78
85. Nievelstein FEM, Fogelman AM, Mottino G, Frank JS. 1991. Lipid accumulation in rabbit aortic intima 2 hours after bolus infusions of low density lipoprotein: a deep-etch and immunolocalization study of rapidly frozen tissue. Arterioscler. Thromb. 11:1795-805
86. Smith EB. 1974. The relationship between plasma and tissue lipids in human atherosclerosis. Adv. Lipid Res. 12:1-49
87. Hoff HF, Heideman CL, Gotto AM Jr, Gaubatz JW. 1977. Apolipoprotein β retention in the grossly normal and atherosclerotic human aorta. Circ. Res. 41:684-90
88. Gerrity RG. 1981. The role of the monocyte in atherogenesis I: transition of blood borne monocytes into foam cells in fatty lesions. Am. J. Path. 103:181-90
89. Schwenke DC, Carew TE. 1989. Initiation of atherosclerotic lesions in cholesterol fed rabbits II: selective retention of LDL vs selective increases in LDL permeability in susceptible sites of arteries. Arteriosclerosis 9:908-18
90. Wagner JD, St. Clair RW, Schwenke DC, Shiveley CA, Adams MR, Clarkson TB. 1992. Regional differences in arterial low density lipoprotein metabolism in surgically postmenopausal cynomolgus monkeys. Effects of estrogen and progesterone replacement therapy. Arterioscler. Thromb. 12:717-26
91. Heinecke JW, Rosen H, Chait A. 1984. Iron and copper promote modification of LDL by human arterial smooth muscle cells. J. Clin. Invest. 74:1890-94
92. Steinbrecher U, Parthasarathy S, Leake DS, Witztum JLC, Steinberg D. 1984. Modification of low density lipoprotein by endothelial cells involves lipid peroxidation and degradation of low density lipoprotein phospholipids. Proc. Natl. Acad. Sci. USA 83:3883-87
93. Palinski W, Rosenfeld ME, Yla-Herttuala S, Gurtner GC, Socher SS, et al. 1989. LDL undergoes oxidative modification in vivo. Proc. Natl. Acad. Sci. USA 86:1372-80
94. Yla-Herttuala S, Palinski W, Rosenfeld M, Parthasarathy S, Carew TE, et al. 1989. Evidence for the presence of oxidatively modified low density lipoprotein in atherosclerotic lesions of rabbit and man. J. Clin. Invest. 84:1086-95
95. Haberland ME, Steinbrecher UP. 1992. Modified low density lipoproteins: diversity and biologic relevance in atherosclerosis. In Molecular Genetics of Coronary Artery Disease, ed. AJ Lusis, JI Rotter, RS Sparkes, pp. 35-61. New York: Karger
96. Witztum JL, Steinberg D. 1991. Role of oxidized low density lipoprotein in atherogenesis. J. Clin. Invest. 88:1785-92
97. Parthasarathy S. 1994. Mechanism(s) of cell-mediated oxidation of low density lipoproteins. In Free Radicals in the Environment, Medicine and Toxicology, ed. H Nohl, H Esterbauer, C Rice Evans, pp. 163-79. London: Richelieu
98. Parthasarathy S. 1994. Modified Lipoproteins in the Pathogenesis of Atherosclerosis, pp. 91-119. Austin, Texas: Landes
99. Navab M, Imes SS, Hama SY, Hough GP, Ross LA, et al. 1991. Monocyte transmigration induced by modification of low density lipoprotein in cocultures of human aortic wall cells is due to induction of monocyte chemotactic protein 1 synthesis and is abolished by high density lipoprotein. J. Clin. Invest. 88:2039-46
100. Berliner JA, Territo MC, Sevanian A, Ramin S, Kim JA, et al. 1990. Minimally modified low density lipoprotein stimulates monocyte endothelial interactions. J. Clin. Invest. 85:1260-66
101. Goldstein JL, Ho YK, Basu SK, Brown MS. 1979. Binding site of macrophages that mediates uptake and degradation of acetylated low density lipoprotein producing massive cholesterol deposition. Proc. Natl. Acad. Sci. USA 76:333-37
102. Sparrow CP, Parthasarathy S, Steinberg D. 1989. A macrophage receptor that recognizes oxidized low density lipoprotein but not acetylated low density lipoprotein. J. Biol. Chem. 264:2599-604
103. Freeman M, Ashkenas J, Rees DJ, Kingsley DM, Copeland NG. et al. 1990. An ancient highly conserved family of cysteine rich protein domains revealed by cloning type I and type II murine macrophage scavenger receptors. Proc. Natl. Acad. Sci. USA 87:8810-14
104. Brown MS, Goldstein JL. 1990. Scavenging for receptors. Nature 343:508-9
105. Parthasarathy S, Young SG, Witztum JL, Pittman RC, Steinberg D. 1986. Probucol inhibits oxidative modification of low density lipoprotein. J. Clin. Invest. 77:641-44
106. Parthasarathy S, Barnett J, Fong LC. 1990. High density lipoprotein inhibits the oxidative modification of low-density lipoprotein. Biochim. Biophys. Acta 1044:275-83
107. Maziere C, Auclair M, Ronveaux MF, Salmon S, Santus RL, et al. Estrogens inhibit copper and cell-mediated modification of low density lipoprotein. Arteriosclerosis 89:175-82
108. Rifici VA, Kachadurian AK. 1992. The inhibition of low-density lipoprotein oxidation by 17-beta estradiol. Metab. Clin. Exp. 41:1110-14
109. Negre-Salvayre A, Pieraggi MT, Mabile L, Salvayre R. 1993. Protective effect of 17-beta estradiol against the cytotoxicity of minimally oxidized LDL to cultured bovine aortic endothelial cells. Atherosclerosis 99:207-17
110. Mooradian AD. 1993. Antioxidant properties of steroids. J. Steroid Biochem. Mol. Biol. 45:509-11
111. Tang M, Abplanalp W, Ayres S, Subbiah MT. 1996. Superior and distinct antioxidant effects of selected estrogen metabolites on lipid peroxidation. Metab. Clin. Exp. 45:411-14
112. Subbiah MT, Kessel B, Agrawal M, Rajan R, Abplanalp W, Rymaszewski Z. 1993. Anti-oxidant potential of specific estrogens on lipid peroxidation. J. Clin. Endocrinol. Metab. 77:1095-97
113. Lacort M, Leal AM, Liza M, Martin C, Martinez R, Ruiz-Larrea MB. 1995. Protective effects of estrogens and catecholestrogens against peroxidative membrane damage in vitro. Lipids 30:141-46
114. Wiseman H. 1994. The antioxidant action of a pure anti-oestrogen: ability to inhibit lipid peroxidation compared to tamoxifen and 17 beta-oestradiol and relevance to its anticancer potential. Biochem. Pharmacol. 47:493-98
115. Keaney JF, Schwaery GT, Xu A, Nicolosi RJ, Loscalzo J, et al. 17β estradiol preserves endothelial vasodilation function and limits low density lipoprotein oxidation in hypercholesterolemic swine. Circulation 89:2251-59
116. Sack MN, Rader DJ, Cannon RO III. 1994. Oestrogen and inhibition of oxidation of low-density lipoproteins in postmenopausal women. Lancet 343:269-70
117. Santanam N, Parthasarathy S. 1995. Cellular cysteine generation does not contribute to the initiation of LDL oxidation. J. Lipid Res. 36:2203-11
118. Wieland E, Parthasarathy S, Steinberg D. 1993. Peroxidase-dependent metalindependent oxidation of low density lipoprotein in vitro: a model for in vivo oxidation. Proc. Natl. Acad. Sci. USA 90:5929-33
119. Anderson WA, Kang YH, DeSombre ER. 1975. Endogenous peroxidase: specific marker enzyme for tissues displaying growth dependency on estrogen. J. Cell Biol. 64:668-81
120. Anderson WA, Gabriel BW, Nerurker SG, Wyche JH, Yates PE, Hanker YS. 1986. Peroxidases induced in rat uterus by estrogen administration. II. Cytochemical and biochemical heterogeneity. J. Submicrosc. Cytol. 18:683-90
121. Hessler JR, Robertson AL Jr, Chisolm GM. 1979. LDL-induced cytotoxicity and endothelial cells in culture. Arteriosclerosis 32:213-29
122. ++ catalyzed oxidation of human low density lipoprotein. FEBS Lett. 257:435-38
123. van Hinsbergh VW, Scheffer M, Havekes L, Kempen JH. 1986. Role of endothelial cells and their products in the modification of low-density lipoproteins. Biochem. Biophys. Acta 878:49-64
124. Watson AD, Navab M, Hama SY, Sevanian A, Prescott SM, et al. 1995. Effect of platelet activating factor-acetyl hydrolase on the formation and action of the minimally oxidized low density lipoprotein. J. Clin. Invest. 95:774-82
125. Stafforini DM, Zimmerman GA, McIntyre TM, Prescott SM. 1993. The platelet activating factor acetyl hydrolase from human plasma prevents oxidative modification of low density lipoprotein. Trans. Assoc. Am. Phys. 105:44-63
126. Mackness MI, Walker CH, Carlson LA. 1987. Low 'A' esterase activity in serum of patients with fish eye disease. Clin. Chem. 35:587-88
127. Mackness MI. 1989. Possible medical signficance of human serum 'A' esterases. In Enzymes Hydrolyzing Organo phosphorous Compounds, ed. E Reiner, WN Aldridge, FCG Hoskin, pp. 202-13. New York: Halsted
128. Mackness MI, Arrol S, Durrington PN. 1991. Paraoxonase prevents accumulation of lipoperoxides in low density lipoprotein. FEBS Lett. 286:152-54
129. Mackness MI, Arrol S, Abbott CA, Durrington PN. 1993. Is paraoxonase related to atherosclerosis? Chem. Biol. Interact. 87:161-67
130. Territo MC, Berliner JA, Almada L, Ramirez R, Fogelman AM. 1989. β-very low density lipoprotein pretreatment of endothelial monolayers increases monocyte adhesion. Atherosclerosis 9:824-28
131. Osborn L, Hession C, Tizard R, Vassallo C, Luhowskyj S, et al. 1989. Direct expression of cloning of vascular cell adhesion molecule-1, a cytokine induced endothelial protein that binds to lymphocytes. Cell 59:1203-11
132. Rice GE, Munro JM, Bevilacqua MP. 1990. Inducible cell adhesion molecule 110 (1NCAM-110) is an endothelial receptor for lymphocytes: a CD 11/CD 18 independent adhesion mechanism. J. Exp. Med. 171:1369-74
133. Cybulsky MI, Gimbrone MA Jr. 1991. Endothelial expression of a mononuclear leukocyte adhesion molecule during atherogenesis. Science 251:788-91
134. Cybulsky MI, Fries JWV, Williams AJ, Sultan P, Gimbrone MA Jr, et al. 1991. Gene structure, chromosomal location, and basis for alternative mRNA splicing of the human VCAM-1 gene. Proc. Natl. Acad. Sci. USA 88:7859-63
135. Elices MJ, Osborn L, Takada Y, Crouse C, Luhowskyj S, et al. 1990. VCAM-1 on activated endothelium interacts with the leukocyte integrin VLA-4 at a site distinct from the VLA-4/fibronectin binding site. Cell 60:577-84
136. Bochner BS, Luscinskas FW, Gimbrone MA Jr, Newman W, Sterbinsky SA, et al. 1991. Adhesion of human basophils, eosinophils, and neutrophils to interleukin-1-activated human vascular endothelial cells: contribution of endothelial cell adhesion molecules. J. Exp. Med. 173:1553-56
137. Li H, Cybulsky MI, Gimbrone MA Jr, Libby P. 1993. VCAM-1, a cytokine regulated mononuclear leukocyte adhesion molecule in rabbit aortic endothelium. Arterioscler. Thromb. 13:197-204
138. O'Brien KD, Allen MD, McDonald TO, Chait A, Harlan JM, et al. 1993. Vascular cell adhesion molecule-1 is expressed in human coronary atherosclerotic plaques: implications for the mode of progression of advanced coronary atherosclerosis. J. Clin. Invest. 92:945-51
139. Kume N, Cybulsky MI, Gimbrone MA Jr. 1992. Lysophosphatidylcholine, a component of atherogenic lipoproteins, induces mononuclear leukocyte adhesion molecules in cultured human and rabbit arterial endothelial cells. J. Clin. Invest. 90:1138-44
140. Kim JA, Territo MC, Wayner E, Carlos TM, Parhami F, et al. 1994. Partial characterization of leukocyte binding molecules on endothelial cells induced by minimally oxidized LDL. Arterioscler. Thromb. 14:427-33
141. Nakai K, Itoh C, Hotta K, Itoh T, Yoshizumi M, Hiramori K. 1994. Estradiol-17 beta regulates the induction of VCAM-1 mRNA expression by interleukin-1 beta in human umbilical vein endothelial cells. Life Sci. 54:221-27
142. Caulin-Glaser T, Watson CA, Pardi R, Bender JR. 1996. Effects of 17 β-estradiol on cytokine-induced endothelial cell adhesion molecule expression. J. Clin. Invest. 98:36-42
143. Cid MC, Kleinman HK, Grant DS, Schnaper HW, Fauci AS, Hoffman GS. 1994. Estradiol enhances leukocyte binding to tumor necrosis factor (TNF)-stimulated endothelial cells via an increase in TNF-induced adhesion molecules E-selection, intracellular adhesion molecule type 1 and vascular cell adhesion molecule type 1. J. Clin. Invest. 93:17-25
144. Aziz KE, Wakefield D. 1996. Modulation of endothelial cell expression of ICAM-1, E-selection and VCAM-1 by beta estradiol, progesterone and dexamethasone. Cell. Immunol. 167:78-85
145. Beato M. 1989. Gene regulation by steroid hormones. Cell 56:335-44
146. Colburn P, Buonassisi V. 1978. Estrogen-binding-sites in endothelial cell cultures. Science 201:817-19
147. 146a. Kirn-Schulze S, McGowan KA, Hubchak SC, Cid MC, Martin MB, et al. 1996. Expression of an estrogen receptor by human coronary artery and umbilical vein endothelial cells. Circulation 94:1402-7
148. Mendelsohn ME, Karas RH. 1994. Estrogen and the blood vesssel. Curr. Opin. Cardiol. 9:619-26
149. Inoue S, Hoshino S, Miyoshi H, Akishita M, Hosoi T, et al. 1996. Identification of a novel isoform of estrogen receptor, a potential inhibitor action of estrogen in vascular smooth muscles. Biochem. Biophys. Res. Commun. 219:766-72
150. Losordo DW, Kearney M, Kim EA, Jekanowski J, Isner JM. 1994. Variable expression of the estrogen receptor in normal and atherosclerotic coronary arteries of premenopausal women. Circulation 89:1501-10
151. Cybulsky MI, Fries JWU, Williams AJ, Sultan P, Eddy R, et al. 1991. Gene structure, chromosomal location and basis for alternative mRNA splicing of the human VCAM-1 gene. Proc. Natl. Acad. Sci. USA 88:7859-63
152. Peppel K, Vinci JM, Baglioni L. 1991. The AU-rich sequences in the 3′ untranslated region mediate the increased turnover of interferon mRNA induced by glucocorticoids. J. Exp. Med. 173:349-55
153. Ribeiro RCJ, Kushner, PJ, Baxter JD. 1995. The nuclear hormone receptor gene superfamily. Annu. Rev. Med. 46:443-53
154. Yang NN, Venugopalan M, Hardikar S, Glasbrook A. 1996. Identification of an estrogen response element activated by metabolites of 17β estradiol and raloxifene. Science 273:1222-25
155. Richards GR, DiAugustine RP, Petrusz P, Clark GC, Sebastian J. 1996. Estradiol stimulates tyrosine phosporylation of the insulin-like growth factor 1 receptor and insulin receptor substrate in the uterus. Proc. Natl. Acad. Sci. USA 93:12,002-7
156. ras/MAP-kinase pathway activation by estradiol receptor complex in MCF-7 cells. EMBO J. 15:1292-300
157. Yla-Herttuala S, Lipton BA, Rosenfeld ME, Sarkioja T, Yoshimura T, et al. 1991. Expression of monocyte chemoattractant protein-1 in macrophage rich areas of human and rabbit atherosclerotic lesions. Proc. Natl. Acad. Sci. USA 88:5252-56
158. Rajavashisth TB, Andalibi A, Territo MC, Berliner JA, Navab M, et al. 1990. Induction of endothelial cell expression of granulocyte and macrophage colony-stimulating factors by modified low density lipoproteins. Nature 344:254-57
159. Clinton SK, Underwood R, Hayes L, Sherman ML, Kufe DW, Libby P. 1992. M-CSF gene expression in vascular cells and in experimental and human atherosclerosis. Am. J. Pathol. 140:301-16
160. Rosenfeld ME, Yla-Herttuala S, Lipton BA, Ord VA, Wutztum JL, Steinberg D. 1992. Macrophage colony-stimulating factor mRNA and protein in atherosclerotic lesions of rabbits and humans. Am. J. Pathol. 140:291-300
161. Cushing SD, Fogelman AM. 1992. Monocytes may amplify their recruitment into inflammatory lesions by inducing monocyte chemoattractant protein-1. Arterioscler. Thromb. 12:78-82
162. Nelken NA, Coughlin SR, Gordon D, Wilcox JN. 1991. Monocyte chemoattractant protein-1 in human atheromatous plaques. J. Clin. Invest. 88:1121-27
163. Frazier-Jessen MR, Kovacs EJ. 1995. Estrogen modulation of JE/monocyte chemoattractant protein-1 mRNA expression in murine macrophages. J. Immunol. 154:1838-45
164. Freter RR, Irminger JC, Porter JA, Jones SD, Stiles CD. 1992. A novel 7-nucleotide motif located in 3′ untranslated sequences of immediate early gene set mediates platelet-derived growth factor induction of the JE gene. Mol. Cell. Biol. 12:5288-300
165. Nathan L, Pervin S, Singh R, Ricks J, Rosenfeld M, Chaudhuri G. 1996. Estradiol reduces monocyte adherence to vascular endothelium in vivo. Circulation 94:151 (Suppl.)
166. Pervin S, Singh, Rosenfeld M, Chaudhuri, Nathan L. 1997. Estradiol supplementation to ovariectomized and hypercholesterolemic rabbits suppressed monocyte chemotactic protein-1 expression in vivo: implications for atherosclerosis. Arterioscler. Thromb. Vasc. Biol. Submitted
167. Furchgott RF, Zawadzki JV. 1980. The obligatory role of endothelial cells in the relaxation of arterial smooth muscle by acetylcholine. Nature 288:373-76
168. Ignarro LJ, Byrns RE, Buga GM, Wood KS. 1987. Endothelium-derived relaxing factor (EDRF) released from artery and vein appears to be nitric oxide (NO) or a closely related radical species. Fed. Proc. 46(3):644 (Abstr.)
169. Palmer RMJ, Ferridge AG, Moncada S. 1987. Nitric oxide release accounts for the biological activity of endothelium-derived relaxing factor. Nature 327:524-26
170. Bath PMW, Hassal DG, Gladwin AM, Palmer RMJ, Martin JF. 1991. Nitric oxide and prostacyclin: divergence of inhibitory effects of monocyte chemotaxis and adhesion to endothelium in vitro. Arterioscler. Thromb. 11:254-60
171. Radomski MW, Palmer RMJ, Moncada S. 1987. Comparative pharmacology of endothelium-derived relaxing factor, nitric oxide and prostacyclin in platelets. Br. J. Pharmacol. 92:181-87
172. Rubanyi GM, Romero JC, Vanhoutte PM. 1986. Flow-induced release of endothelium derived relaxing factor. Am. J. Physiol. 250:1145-49
173. Lamontagne D, Pohl V, Busse R. 1992. Mechanical deformation of vessel wall and shear stress determine the basal EDRF release in the intact coronary vascular bed. Circ. Res. 70:123-30
174. Cooke JP, Stamler JS, Andon N, Davies PF, Loscalzo J. 1990. Flow stimulates endothelial cells to release a nitrova-sodilator that is potentiated by reduced thiols. Am. J. Physiol. 28:H804-12
175. Buga GM, Gold ME, Fukuto JM, Ignarro LJ. 1991. Shear stress-induced release of nitric acid from endothelial cells grown on beads. Hypertension 17:187-93
176. Andrews HE, Bruckdorfer KR, Dunn RC, Jacobs M. 1987. Low density lipoproteins inhibit endothelium-dependent relaxation in rabbit aorta. Nature 327:237-39
177. Hayashi T, Naito M, Ishikawa T, Kuzuya M, Funaki C, et al. 1989. Migrating very low density lipoprotein attenuates endothelium dependent relaxation in rabbit atherosclerotic aortas. Blood Vessels 26:290-99
178. Kugiyama K, Bucay M, Morrissett JD, Roberts R, Henry PD. 1989. Oxidized LDL impairs endothelium dependent arterial relaxation. Circulation 80(2):279
179. Galle J, Mulsch A, Busse R, Bassenge E. 1991. Effects of native and oxidized low density lipoproteins on formation and inactivation of endothelium-derived relaxing factor. Arterioscler. Thromb. 11:198-203
180. Galle J, Bauersachs J, Busse R, Bassenge E. 1992. Inhibition of cyclic-AMP and cyclic GMP mediated dilations in isolated arteries by oxidized low density lipoproteins. Arterioscler. Thromb. 12:180-86
181. Tanner FC, Noll G, Boulanger CM, Luscher TF. 1991. Oxidized low density lipoproteins inhibit relaxations of porcine coronary arteries. Circulation 83:2012-20
182. Furchgott RF. 1988. Studies on the relaxation of rabbit aorta by sodium nitrite: the basis for the proposal that the acid-activatable factor from bovine retractor penis is inorganic nitrite and the endothelium-derived relaxing factor is nitric oxide. In Mechanisms of Vasodilation, ed. PM Vanhoutte, pp. 401-14. New York: Raven
183. Minor RL Jr, Myers PR, Guerra R Jr, Bates JN, Harrison DG. 1990. Diet induced atherosclerosis increases the release of nitrogen oxides from rabbit aorta. J. Clin. Invest. 86:2109-16
184. Palmer RMJ, Ashton DS, Moncada S. 1988. Vascular endothelial cells synthesize nitric oxide from L-arginine. Nature 333:664-66
185. Cooke JP, Singer AH, Tsao P, Zera P, Rowean RA, Billingham ME. 1992. Antiatherogenic effects of L-arginine in the hypercholesterolemic rabbit. J. Clin. Invest. 90:1168-12
186. Candipan RC, Wang BY, Buitrago R, Tsao PS, Cooke JP. 1996. Regression or progression. Dependency on vascular nitric oxide. Arterioscler. Thromb. Vasc. Biol. 16:44-50
187. Tsao PS, McEvoy LM, Drexler H, Butcher EC, Cooke JP. 1994. Enhanced endothelial adhesiveness in hypercholesterolemia is attenuated by L-arginine. Circulation 89:2176-82
188. Deleted in proof
189. Hayashi T, Fukuto JM, Ignarro LJ, Chaudhuri G. 1992. Basal release of nitric oxide from aortic rings is greater in female rabbits than in male rabbits: implications in atherosclerosis. Proc. Natl. Acad. Sci. USA 89:11259-63
190. Weiner CP, Lizasoain I, Baylis SA, Knowles RG, Charles IG, Moncada S. 1994. Induction of calcium-dependent nitric oxide synthases by sex hormones. Proc. Natl. Acad. Sci. USA 88:5212-19
191. ++-calmodulin dependent mechanism. Biochem. Biophys. Res. Commun. 203:1013-19
192. Schray-Utz B, Zelher AM, Busse R. 1993. Expression of constitutive NO synthase in cultured endothelial cells is enhanced by 17β estradiol. Circulation 88:80
193. Hayashi T, Yamada K, Esaki T, Kuzuya M, Satake S, et al. 1995. Estrogen increases endothelial nitric oxide by a receptor mediated system. Biochem. Biophys. Res. Commun. 214:847-55
194. Hishikawa K, Nakaki T, Marumo T, Suzuki H, Kato R, Saruta T. 1995. Upregulation of nitric oxide synthase by estradiol in human aortic endothelial cells. FEBS Lett. 360:291-93
195. Furuya K, Chaudhuri G. 1992. Estradiol does not influence myocardial superoxide dismutase activity in rabbits. J. Cardiovasc. Pharmacol. 22:65-68
196. Zeiher AM, Fisslthaler B, Schray-Utz B, Busse R. 1995. Nitric oxide modulates the expression of monocyte chemoattractant protein 1 in cultured human endothelial cells. Circ. Res. 76:980-86
197. DeCaterina R, Libby P, Peng HB, Thannickal VJ, Rajavshisth TB, et al. 1995. Nitric oxide decreases cytokine-induced endothelial activation. Nitric oxide selectively reduces endothelial expression of adhesion molecules and proinflammatory cytokines. J. Clin. Invest. 96:60-68
198. Pervin S, Singh R, Tong L, Rosenfeld M, Chaudhuri G, Nathan L. 1996. The interrelationship between expression of endothelial nitric oxide synthase and vascular cell adhesion molecule-1 and the modulating role of estradiol. Circulation 94:220 (Suppl.)
199. Kaye AM, Weisman Y, Harell A, Somjen D. 1990. Hormonal stimulation of bone cell proliferation. J. Steroid Biochem. Mol. Biol. 37:431-35
200. Burk O, Klempnauer KH. 1991. Estrogen dependent alterations in differentiation state of myeloid cells caused by a V-myb/estrogen receptor fusion protein. EMBO J. 10:3713-19
201. Liel Y, Kraus S, Levy J, Shany S. 1992. Evidence that estrogens modulate activity and increase the number of 1,25-dihydroxy vitamin D receptors in osteoblast-like cells (ROS 17/2.8). Endocrinology 130:2597-601
202. Miller L, Hunt JS. 1996. Sex steroid hormones and macrophage function. Life Sci. 59:1-14
203. Gulshan S, McCruden AB, Stimson WH. 1990. Oestrogen receptors in macrophages. Scand. J. Immunol. 31:691-97
204. Hibbs JB Jr, Taintor RR, Vavzin Z, Rachlin EM. 1988. Nitric oxide: a cytotoxic activated macrophage effector molecule. Biochem. Biophys. Res. Commun. 157:87-94
205. Stuehr DJ, Gross SS, Sakuma I, Levi R, Nathan CF. 1989. Activated murine macrophages secrete a metabolite of arginine with the bioactivity of endothelium-derived relaxing factor and the chemical reactivity of nitric oxide. J. Exp. Med. 169:1011-20
206. Chang GJ, Woo P, Honda HM, Ignarro LJ, Young L, et al. 1994. Oxidation of LDL to a biologically active form by derivatives of nitric oxide and nitrite in the absence of superoxide. Dependence on pH and oxygen. Anerioscler. Thromb. 14:1808-14
207. Rubbo H, Parthasarathy S, Barnes S, Kirk M, Kalynaraman B, et al. 1995. Nitric oxide inhibition of lipoxygenase dependent liposome and low-density lipoprotein oxidation: termination of radical chain propagation reactions and formation of nitrogen-containing oxidized lipid derivatives. Arch. Biochim. Biophys. 324:15-25
208. Jessup W, Mohr D, Gieseg SP, Dean RT, Stocker R. 1992. The participation of nitric oxide in cell free-and its restriction of macrophage mediated oxidation of low density lipoprotein. Biochim. Biophys. Acta 1180:73-82
209. Yates MT, Lambert LE, Whitten JP, McDonald I, Mano M. 1992. A protective role for nitric oxide in the oxidative modification of low density lipoproteins by mouse macrophages. FEBS Lett. 309:135-38
210. Struck AT, Hogg N, Thomas JP, Kalyanaraman B. 1995. Nitric oxide donor compounds inhibit the toxicity of oxidized low-density lipoprotein to endothelial cells. FEBS Lett. 361:291-94
211. Kauser K, Sonnenberg D, Henrichmann F, Rubanyi GM. 1994. 17β estradiol inhibits IL-1β induced suppression of contractile reactivity in isolated rat thoracic aorta. Circulation 90:1577
212. Miller L, Alley EW, Murphy WJ, Russell SW, Hunt JS. 1996. Progesterone inhibits inducible nitric oxide synthase gene expression and nitric oxide production in murine macrophages. J. Leukocyte Biol. 59:442-50
213. Shanker G, Sorci-Thomas M, Register TC, Adams MR. 1994. The inducible expression of THP-1 cell interleukin-1 mRNA: effects of estrogen on differential response to phorbol ester and lipopolysaccharide. Lymphokine Cytokine Res. 13:1-7
214. Libby P, Hansson GK. 1991. Involvement of the immune system in human atherogenesis: current knowledge and unanswered questions. Lab. Invest. 64:5-15
215. McMurray HF, Parthasarathy S, Steinberg D. 1993. Oxidatively modified low density lipoprotein is a chemoattractant for human T lymphocytes. J. Clin. Invest. 92:1004-8
216. Taub DD, Proost P, Murphy WJ, Anver M, Longo DL, et al. 1995. Monocyte chemotactic protein-1 (MCP-1), -2 and -3 are chemotactic for human Tlymphocytes. J. Clin. Invest. 95:1370-76
217. Fischer-Dzoga K, Wissler RW, Vesselinovitch D. 1983. The effect of estradiol on the proliferation of rabbit aortic medial tissue cells induced by hyperlipemic serum. Exp. Mol. Pathol. 39:355-63
218. Vargas R, Wroblewska B, Rego A, Hatch J, Ramwell PW. 1993. Oestradiol inhibits smooth muscle cell proliferation of pig coronary artery. Br. J. Pharmacol. 109:612-17
219. Foegh ML, Asotra S, Howell MH, Ramwell PM. 1994. Estradiol inhibition of arterial neointimal hyperplasia after balloon injury. J. Vasc. Surg. 19:722-26
220. Sullivan TR Jr, Karas RH, Aronovitz M, Faller GT, Ziar JP, et al. 1995. Estrogen inhibits the response-to-injury in a mouse carotid artery model. J. Clin. Invest. 96:2482-88
221. Clowes AW, Reidy MA, Clowes MM. 1983. Mechanisms of stenosis after arterial injury. Lab. Invest. 49:208-15
222. Garg UC, Hassad A. 1989. Nitric oxide-generating vasodilators and 8-bromo-cyclic guanosine monophosphate inhibit mitogenesis and proliferation of cultured rat vascular smooth muscle cells. J. Clin. Invest. 83:1774-77
223. Sarkar R, Webb RC, Stanley JC. 1995. Nitric oxide inhibition of endothelial cell mitogenesis and proliferation. Surgery 118:274-79
224. Newby AC, Southgate KM, Assender JW. 1992. Inhibition of vascular smooth muscle cell proliferation by endothelium dependent vasocilators. Herz 175:291-99
225. Mooradian DL, Hutsell TC, Keefer LK. 1995. Nitric oxide (NO) donor molecules: effect of NO release on vascular smooth muscle cell proliferation in vitro. J. Cardiovasc. Pharmacol. 25:674-78
226. Chesebro JH, Lam JYT, Badimon L, Fuster V. 1987. Restenosis after arterial angioplasty: a hemokeologic response to injury. Am. J. Cardiol. 60:10B-16B
227. Tzeng E, Shears LL II, Robbins PD, Pitt BR, Geller DA, et al. 1996. Vascular gene transfer of the human inducible nitric oxide synthase: characterization of activity and effects on myointimal hyperplasia. Mol. Med. 2:211-25
228. Sarkar R, Meinberg EG, Stanley JC, Gordon D, Webb RC. 1996. Nitric oxide reversibly inhibits the migration of cultured vascular smooth muscle cells. Circ. Res. 78:225-30
229. Kolpakov V, Gordon D, Kulik TJ. 1995. Nitric oxide-generating compounds inhibit total protein and collagen synthesis in cultured vascular smooth muscle cells. Circ. Res. 76:305-9
230. Frazier-Jessen MR, Mott FJ, Witte PL, Kovacs EJ. 1996. Estrogen suppression of connective tissue deposition in a murine model of peritoneal adhesion formation. J. Immunol. 156:3036-42
231. Watson KE, Bostrom K, Ravindranath R, Lam T, Norton B, Demer LL. 1994. TGF-β-1 and 25-hydroxy cholesterol stimulate osteoblast like vascular cells to calcify. J. Clin. Invest. 93:2106-13
232. Morales DE, McGowan KA, Grant DS, Maheshwari S, Bhartiya D, et al. 1995. Estrogen promotes angiogenic activity in human umbilical vein endothelial cells in vitro and in a murine model. Circulation 91:155-63
233. Miller ME, Dores GM, Thorpe SL, Akerley WL. 1994. Paradoxical influence of estrogenic hormones on platelet-endothelial cell interactions. Thromb. Res. 74:577-94
234. Karpati L, Chow FPR, Woollard ML, Hutton RAZ, Dandona P. 1980. Prostacyclin like activity in the female rat thoracic aorta and the inferior vena cava after ethinyl oestradiol and norethisterone. Clin. Sci. 59:369-72
235. Schroeder JS, Bolten JL, Quint RA, Clark DA, Hayden WG, et al. 1977. Provocation of coronary spasm with ergonovine maleate. Am. J. Cardiol. 40:487-91
236. Waters DD, Szlacheic J, Boram R, Miller DD, Danwe F, Theroux P. 1983. Comparative sensitivity of exercise, cold presser and ergonovine testing in provoking attacks of variant angina in patients with active disease. Circulation 67:310-15
237. Herstand DD, Armstrong ML, Marcus ML, Piegors DJ, Mark AL. 1991. Augmented responses to vasoconstrictor stimuli in hypercholesterolemic and atherosclerotic monkeys. Circ. Res. 54:711-18
238. Rosano GMC, Sarrel PM, Poole-Wilson PA, Collins P. 1993. Beneficial effect of oestrogen on exercise-induced myocardial ischaemia in women with coronary artery disease. Lancet 342:133-36
239. Gilligan DM, Bader DM, Panza JA, Quyyumi AA, Cannon RD III. 1994. Acute vascular effects of estrogen in postmenopausal women. Circulation 90:786-91
240. Raddino R, Manca C, Poli E, Bolognesi R, Visioli O. 1986. Effects of 17β estradiol on the isolated rabbit heart. Arch. Int. Pharmacolyn. 281:57-65
241. 2 α-mediated contraction of the porcine coronary artery. AW. Prost. Thromb. Leuk. Res. 19:277-80
242. Galle S, Busse R, Bassenge E. 1991. Hypercholesterolemia and artherosclerosis change vascular reactivity in rabbits by different mechanisms. Arterioscler. Thromb. 11:1712-18
243. Freiman PC, Mitchell GG, Heistad DD, Armstrong ML, Harrison DG. 1986. Atherosclerosis impairs endotnelium-dependent vascular relaxation to acetylcholine and thrombin in primates. Circ. Res. 58:783-89
244. Ludmer PL, Selwyn AP, Shovk TL, Wayne RR, Mudge RH, et al. 1986. Paradoxical vasoconstriction induced by acetylcholine in atherosclerotic coronary arteries. N. Engl. J. Med. 315:1046-51
245. Gisclard V, Miller VM, Vanhoutte P. 1988. Effect of 17 beta-estradiol on endothelium-dependent responses in the rabbit. J. Pharmacol. Exp. Ther. 244:19-22
246. Miller VM, Aarhus LL, Vanhoutte PM. 1988. Effects of estrogens on adrenergic and endothermic-dependent responses in the ovarian artery of the rabbit. In Proc. 2nd Int. Symp. Resistance Arteries, ed. W Halpern, J Brayden, M McLaughlin, G Oslo, BL Pegham, K Machey, pp. 136-45 Ithaca, NY: Perinatology
247. Kauser K, Rubanyi GM. 1995. Gender difference in endothelial dysfunction in the aorta of spontaneously hypertensive rats. Hypertension 25:517-23
248. Kauser K, Sonnenberg D, Mertens H, Werner M, Wilson K, Polokoff R, et al. 1995. Vasculoprotective effect of 17β-estradiol in high cholesterol fed, ovariectomized rabbits. FASEB J. 9:A854
249. Bell DR, Rensberger HJ, Koritnik DR, Koshy A. 1995. Estrogen pretreatment directly potentiates endothelium-dependent vasorelaxation of porcine coronary arteries. Am. J. Physiol. 268:H377-83
250. Miller VM, Vanhoutte PM. 1992. Effects of female steroid hormones on endothelium-derived factors and vascular function. In Steroid Hormones and Uterine Bleeding, ed. NJ Alexander, C d' Arcangues, pp. 299-306. Washington DC: AAAS. 344 pp.
251. Williams JK, Adams MR, Klopfenstein HS. 1990. Estrogen modulates responses of atherosclerotic coronary arteries. Circulation 81:1680-87
252. Williams JK, Adams MR, Herrington DM, Clarkson TB. 1992. Short-term administration of estrogen and vascular responses of atherosclerotic coronary arteries J. Am. Coll. Cardiol. 20:452-57
253. Hashimoto M, Akishita M Eto M, Ishikawa M, Kozaki K, et al. 1995. Modulation of endothelium-dependent flow-mediated dilatation of the brachial artery by sex and menstrual cycle. Circulation 92:3431-35
254. Gilligan DM, Quyyumi AA, Cannon RO. 1994. Effects of physiological levels of estrogen on coronary vasomotor function in postmenopausal women. Circulation 89:2545-51
255. Reis SE, Gloth ST, Blumenthal RS, Resar JR, Zacur HA, et al. 1994. Ethinyl estradiol acutely attenuates abnormal coronary vasomotor responses to acetylcholine in postmenopausal women. Circulation 89:52-60
256. Reis SE, Blumenthal RS, Gloth ST, Resar JR, Gerstenblith G, Brinken JA. 1994. Estrogen acutely abolishes cold-induced coronary vasoconstriction in postmenopausal women. Circulation 90:457 (Abstr.)
257. Zeiher AM, Drexler H, Wollschlager H, Just H. 1991. Endothelial dysfunction of the coronary microvasculature is associated with coronary blood flow regulation in patients with early atherosclerosis. Circulation 84:1984-92
258. Gilligan DM, Badar DM, Panza JA, Quyyumi AA, Cannon RO III. 1995. Effects of estrogen replacement therapy on peripheral vasomotor function in postmenopausal women. Am. J. Cardiol. 75:264-68
259. Busse R, Fleming I. 1996. Endothelial dysfunction in atherosclerosis. J. Vasc. Res. 33:181-94
260. Mikkola T, Turunen P, Arela K, Orpana A, Viinikka L, Ylikorkala O. 1995. 17β-estradiol stimulates prostacyclin, but not endothelin-1, production in human vascular endothelial cells. J. Clin. Endocrinol. Metab. 80:1832-36
261. Corvazier E, Dupuy E, Dosne AM, Maclouf J. 1984. Minimal effect of estrogens on endothelial cell growth and production of prostacyclin. Thromb. Res. 34:303-10
262. 2-like material in the rabbit. Prostaglandins 20:1039-51
263. Redmond EM, Cherian MN, Wetzel RC. 1994. 17 beta-estradiol inhibits flow-and acute hypoxia-induced prostacyclin release from perfused endocardial endothelial cells. Circulation 90:2519-24
264. Chester AH, Jiang C, Borland JA, Yacoub MH, Collins P. 1995. Oestrogen relaxes human epicardial coronary arteries through non-endothelium-dependent mechanisms. Coronary Artery Dis. 6:417-22
265. Mugge AM, Riedl M, Barton M, Kuhn M, Lichtlen PR. 1993. Endothelium independent relaxation of human coronary arteries by 17β oestradiol in vitro. Cardiavasc. Res. 27:1939-42
266. ++ channels through a c-GMP-dependent mechanism. Circ. Res. 77:936-42
267. 2 α-mediated contraction of the porcine coronary artery. Adv. Prost. Thromb. Leuk. Res. 19:277-80
268. 2 in porcine coronary artery. Circulation 91:2619-26
269. ++ currents in A7r5 vascular smooth muscle cell line. Am. J. Physiol. 266:C975-80
270. Sudhir K, Chou TM, Mullen WL, Hausmann D, Collins P, et al. 1995. Mechanisms of estrogen-induced vasodilation: in vivo studies in canine coronary conductance and resistance arteries. J. Am. Coll. Cardiol. 26:807-14
271. Deleted in proof
272. Crook D, Cust MP, Gangar KF, Worthington M, Hillard TC, et al. 1992. Comparison of transdermal and oral estrogen-progestin replacement therapy: effects on serum lipids and lipoproteins. Obstet. Gynecol. 166:950-55
273. Pang SC, Greendale GA, Cedars MI, Gambone JC, Lozano K, et al. 1993. Long-term effects of transdermal estradiol with and without medroxyprogesterone acetate. Fertil. Steril. 59:76-82
274. McDonald CC, Alexander FE, Whyte BW, Forrest AP, Steward HJ. 1995. Cardiac and vascular morbidity in women receiving adjuvant tamoxifen for breast cancer in a randomised trial. The Scottish Cancer Trials Breast Group. Br. Med. J. 311:977-80
275. Love RR, Wiebe DA, Newcomb PA, Cameron L, Leventhal H, et al. 1991. Effects of tamoxifen on cardiovascular risk factors in postmenopausal women. Ann. Intern. Med. 115:860-64
276. Miller VT, Muesing RA, LaRosa JC, Stoy DB, Phillips EA, Stillman RJ. 1991. Effects of conjugated equine estrogens with and without three different progestogens on lipoproteins, high density lipoprotein subfractions and apolipoprotein A-I. Obstet. Gynecol. 77:235-40
277. The Writing Group for the PEPI Trial. 1995. Effects of estrogen or estrogen/progestin regimens on heart disease risk factors in postmenopausal women. The Postmenopausal Estrogen/Progestin Interventions (PEPI) trial. JAMA 273:199-208
278. Grodstein F, Stampfer MJ, Manson JE, Colditz GA, Willett WC, et al. 1996. Postmenopausal estrogen and progestin use and the risk of cardiovascular disease. N. Engl. J. Med. 335:453-61
279. Williams JK, Honore EK, Washburn SA, Clarkson TB. 1994. Effects of hormone replacement therapy on reactivity of atherosclerotic coronary arteries in cynomolgus monkeys. J. Am. Coll. Cardiol. 24:1757-61
280. Coronary Drug Project Research Group. 1970. The coronary drug project: initial findings leading to modification of its research protocol. JAMA 214:1303-13